Cargando…

Medication Adherence in Type 2 Diabetes Mellitus: A Qualitative Exploration of Barriers and Facilitators From Socioecological Perspectives

Adherence to antidiabetic medications (ADMs) remains a serious challenge among type 2 diabetes mellitus (T2DM) patients. Factors affecting medication adherence are not fully understood in Nigeria. This qualitative study explored patients’ views on barriers and facilitators of medication adherence. D...

Descripción completa

Detalles Bibliográficos
Autores principales: Onwuchuluba, EE, Oyetunde, OO, Soremekun, RO
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317237/
https://www.ncbi.nlm.nih.gov/pubmed/34368436
http://dx.doi.org/10.1177/23743735211034338
_version_ 1783730031999057920
author Onwuchuluba, EE
Oyetunde, OO
Soremekun, RO
author_facet Onwuchuluba, EE
Oyetunde, OO
Soremekun, RO
author_sort Onwuchuluba, EE
collection PubMed
description Adherence to antidiabetic medications (ADMs) remains a serious challenge among type 2 diabetes mellitus (T2DM) patients. Factors affecting medication adherence are not fully understood in Nigeria. This qualitative study explored patients’ views on barriers and facilitators of medication adherence. Data collection was through face-to-face, semistructured, in-depth interviews conducted on 25 purposively sampled patients attending a public tertiary hospital. The interviews were audio recorded, transcribed verbatim, and analyzed using thematic analysis based on socioecological framework. NVIVO version 10 identified more codes. Most commonly identified barriers were organizational (clinic structure), personal (perception of T2DM as a dangerous illness), interpersonal (lack of spousal support), and community (concerns about taking ADMs in social gatherings). It was observed that female patients received more spousal support than the males. The facilitators of adherence include perceiving medication-taking a routine, the need to live longer, having savings for ADMs, purchasing medications to last until the next clinic visit. This study identified barriers and facilitators unique to Nigerian T2DM patients. Interventions anchored on these factors would improve medication adherence.
format Online
Article
Text
id pubmed-8317237
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-83172372021-08-06 Medication Adherence in Type 2 Diabetes Mellitus: A Qualitative Exploration of Barriers and Facilitators From Socioecological Perspectives Onwuchuluba, EE Oyetunde, OO Soremekun, RO J Patient Exp Research Article Adherence to antidiabetic medications (ADMs) remains a serious challenge among type 2 diabetes mellitus (T2DM) patients. Factors affecting medication adherence are not fully understood in Nigeria. This qualitative study explored patients’ views on barriers and facilitators of medication adherence. Data collection was through face-to-face, semistructured, in-depth interviews conducted on 25 purposively sampled patients attending a public tertiary hospital. The interviews were audio recorded, transcribed verbatim, and analyzed using thematic analysis based on socioecological framework. NVIVO version 10 identified more codes. Most commonly identified barriers were organizational (clinic structure), personal (perception of T2DM as a dangerous illness), interpersonal (lack of spousal support), and community (concerns about taking ADMs in social gatherings). It was observed that female patients received more spousal support than the males. The facilitators of adherence include perceiving medication-taking a routine, the need to live longer, having savings for ADMs, purchasing medications to last until the next clinic visit. This study identified barriers and facilitators unique to Nigerian T2DM patients. Interventions anchored on these factors would improve medication adherence. SAGE Publications 2021-07-26 /pmc/articles/PMC8317237/ /pubmed/34368436 http://dx.doi.org/10.1177/23743735211034338 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Research Article
Onwuchuluba, EE
Oyetunde, OO
Soremekun, RO
Medication Adherence in Type 2 Diabetes Mellitus: A Qualitative Exploration of Barriers and Facilitators From Socioecological Perspectives
title Medication Adherence in Type 2 Diabetes Mellitus: A Qualitative Exploration of Barriers and Facilitators From Socioecological Perspectives
title_full Medication Adherence in Type 2 Diabetes Mellitus: A Qualitative Exploration of Barriers and Facilitators From Socioecological Perspectives
title_fullStr Medication Adherence in Type 2 Diabetes Mellitus: A Qualitative Exploration of Barriers and Facilitators From Socioecological Perspectives
title_full_unstemmed Medication Adherence in Type 2 Diabetes Mellitus: A Qualitative Exploration of Barriers and Facilitators From Socioecological Perspectives
title_short Medication Adherence in Type 2 Diabetes Mellitus: A Qualitative Exploration of Barriers and Facilitators From Socioecological Perspectives
title_sort medication adherence in type 2 diabetes mellitus: a qualitative exploration of barriers and facilitators from socioecological perspectives
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317237/
https://www.ncbi.nlm.nih.gov/pubmed/34368436
http://dx.doi.org/10.1177/23743735211034338
work_keys_str_mv AT onwuchulubaee medicationadherenceintype2diabetesmellitusaqualitativeexplorationofbarriersandfacilitatorsfromsocioecologicalperspectives
AT oyetundeoo medicationadherenceintype2diabetesmellitusaqualitativeexplorationofbarriersandfacilitatorsfromsocioecologicalperspectives
AT soremekunro medicationadherenceintype2diabetesmellitusaqualitativeexplorationofbarriersandfacilitatorsfromsocioecologicalperspectives